Product Information
SAXAGLIPTIN HCL 2.5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $1.1813 per EA under NDC 65862082590. Its NADAC has been published 28 times since Dec 17, 2025.
Strength
2.5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862082590
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
SAXAGLIPTIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA205972On Market Since
7/31/2023
Pharmacological Classes
Price Statistics
The NADAC for SAXAGLIPTIN HCL 2.5 MG TABLET has been published 28 times since Dec 17, 2025, and over the history we have for it it has declined 52.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1813 per EA |
|---|---|
| All-time high | $2.4647 (Jan 14, 2026) |
| All-time low | $1.1813 (Jun 17, 2026) |
| 52-week high | $2.4647 |
| 52-week low | $1.1813 |
| Median price | $1.5160 |
| Average price | $1.7373 |
| Largest weekly change | -18.3% (Mar 18, 2026) |
| Weeks tracked | 28 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of SAXAGLIPTIN HCL 2.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SAXAGLIPTIN HCL 2.5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $1.1813 per EA (NDC 65862082590), effective Jun 24, 2026.
How has the price of SAXAGLIPTIN HCL 2.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for SAXAGLIPTIN HCL 2.5 MG TABLET has declined 52.1%. It has been tracked across 28 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for SAXAGLIPTIN HCL 2.5 MG TABLET?
Since Dec 17, 2025, the NADAC for SAXAGLIPTIN HCL 2.5 MG TABLET has ranged from a low of $1.1813 (Jun 17, 2026) to a high of $2.4647 (Jan 14, 2026), with a median of $1.5160 per EA.
Are there cheaper alternatives to SAXAGLIPTIN HCL 2.5 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as SAXAGLIPTIN HCL 2.5 MG TABLET, but none are currently priced below it.
Who manufactures SAXAGLIPTIN HCL 2.5 MG TABLET?
SAXAGLIPTIN HCL 2.5 MG TABLET (NDC 65862082590) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Related Drugs
Same classification